Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls.

Environmental research·2026
Same author

ImmuSeeker: deep mining of immune-related gene family signatures through lineage reconstruction.

Genome biology·2026
Same author

Machine learning framework for early identification of high-spending Crohn's disease patients using administrative claims.

BMJ health & care informatics·2026
Same author

Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer's disease pathology.

The journal of prevention of Alzheimer's disease·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Multiple sclerosis risk stratification and healthcare cost prediction using machine learning.

Communications medicine·2025

Related Experiment Video

Updated: Jun 29, 2025

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K

Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and

Lukasz S Wylezinski1, Cheryl L Sesler2, Guzel I Shaginurova2

  • 1Decode Health, Inc., Nashville, Tennessee; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

The Journal of Molecular Diagnostics : JMD
|March 24, 2024
PubMed
Summary

Researchers identified RNA biomarkers to differentiate neuromyelitis optica (NMO) from relapsing-remitting multiple sclerosis (RRMS) using machine learning. This discovery accelerates new methods for disease detection and therapeutic development.

More Related Videos

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
09:49

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing

Published on: December 3, 2019

10.9K
Production of RNA for Transcriptomic Analysis from Mouse Spinal Cord Motor Neuron Cell Bodies by Laser Capture Microdissection
11:46

Production of RNA for Transcriptomic Analysis from Mouse Spinal Cord Motor Neuron Cell Bodies by Laser Capture Microdissection

Published on: January 13, 2014

10.7K

Related Experiment Videos

Last Updated: Jun 29, 2025

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K
Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
09:49

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing

Published on: December 3, 2019

10.9K
Production of RNA for Transcriptomic Analysis from Mouse Spinal Cord Motor Neuron Cell Bodies by Laser Capture Microdissection
11:46

Production of RNA for Transcriptomic Analysis from Mouse Spinal Cord Motor Neuron Cell Bodies by Laser Capture Microdissection

Published on: January 13, 2014

10.7K

Area of Science:

  • Neuroimmunology
  • Genomics
  • Computational Biology

Background:

  • Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are distinct inflammatory demyelinating diseases of the central nervous system.
  • Accurate differentiation between NMO and RRMS is crucial for appropriate treatment and management.
  • Current diagnostic methods can be challenging, necessitating the search for novel biomarkers.

Purpose of the Study:

  • To identify RNA biomarkers that can reliably distinguish NMO from RRMS in treatment-naïve patients.
  • To explore potential therapeutic applications for NMO and RRMS using machine learning (ML) and pathway analysis.
  • To leverage RNA sequencing data and multivariate approaches for enhanced disease detection and therapeutic target identification.

Main Methods:

  • Utilized an ensemble approach combining differential gene expression analysis and competitive ML methods on total RNA sequencing data from peripheral whole blood.
  • Analyzed data from treatment-naïve patients with RRMS, NMO, and healthy controls.
  • Performed pathway analysis to understand biological context, transcription factor activity, and small-molecule therapeutic potential.

Main Results:

  • Developed ML models that accurately differentiate NMO from RRMS patients, with performance exceeding 90% accuracy.
  • Identified RNA biomarkers associated with ribosomal dysfunction and viral infection as key drivers of model performance.
  • Uncovered small-molecule candidates, including mitoxantrone and vorinostat, capable of reversing perturbed gene expression and reinforcing discovered signatures.

Conclusions:

  • Putative RNA biomarkers were identified that accurately distinguish NMO from RRMS and healthy individuals.
  • Multivariate analysis of RNA sequencing data enhances the discovery of unique RNA biomarkers, accelerating development of new diagnostic and therapeutic strategies.
  • Integrating biological understanding with RNA biomarker discovery facilitates the identification of disease-specific signatures and potential therapeutic targets.